Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04652076
Title GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab (GYNET)
Acronym GYNET
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors NETRIS Pharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHRU BESANCON - Hopital Jean Minjoz Besançon France Details
Institut Bergonié Bordeaux France Details
Centre François Baclesse Caen France Details
Centre Georges François Leclerc Dijon France Details
Primary Completion Date Lille France Details
Centre Léon Bérard Lyon France Details
Primary Completion Date Marseille France Details
ICM - Val d'Aurelle Montpellier France Details
Insitut de cancérologie de l'ouest Nantes France Details
Hopital de la Croix Saint Simon Paris 75020 France Details
Institut Curie (Site Saint Cloud) Paris 92210 France Details
Institut Gustave Roussy Paris 94800 France Details
Aphp Cochin Paris France Details
Centre Eugène Marquis Rennes France Details
Institut claudius Regaud Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field